BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serpa MS, Mafra RP, Queiroz SIML, Silva LPD, Souza LBD, Pinto LP. Expression of urokinase-type plasminogen activator and its receptor in squamous cell carcinoma of the oral tongue. Braz oral res 2018;32. [DOI: 10.1590/1807-3107bor-2018.vol32.0093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xi L, Yang Y, Xu Y, Zhang F, Li J, Liu X, Zhang Z, Du Q. The enhanced genomic 6 mA metabolism contributes to the proliferation and migration of TSCC cells. Int J Oral Sci 2022;14:11. [PMID: 35177638 DOI: 10.1038/s41368-022-00161-9] [Reference Citation Analysis]
2 Metrangolo V, Ploug M, Engelholm LH. The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities. Cancers (Basel) 2021;13:5376. [PMID: 34771541 DOI: 10.3390/cancers13215376] [Reference Citation Analysis]
3 Mafra RP, Sabino VG, Rolim LSA, de Carvalho CHP, Nonaka CFW, Barboza CAG, de Souza LB, Pinto LP. Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis. Exp Mol Pathol 2021;124:104722. [PMID: 34800515 DOI: 10.1016/j.yexmp.2021.104722] [Reference Citation Analysis]
4 Nayak S, Bhatt MLB, Goel MM, Gupta S, Mehrotra D, Mahdi AA, Mishra A. Aberrant Expression of PTPN-14 and Wilms’ Tumor 1 as Putative Biomarker for Locoregional Recurrence in Oral Squamous Cell Carcinoma. Asian Journal of Oncology 2022;8:29-41. [DOI: 10.1055/s-0041-1731128] [Reference Citation Analysis]
5 Zhao LL. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3+ regulatory T cells. J Bioenerg Biomembr 2020;52:279-89. [PMID: 32594290 DOI: 10.1007/s10863-020-09840-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Baart VM, van Duijn C, van Egmond SL, Dijckmeester WA, Jansen JC, Vahrmeijer AL, Sier CFM, Cohen D. EGFR and αvβ6 as Promising Targets for Molecular Imaging of Cutaneous and Mucosal Squamous Cell Carcinoma of the Head and Neck Region. Cancers (Basel) 2020;12:E1474. [PMID: 32516897 DOI: 10.3390/cancers12061474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Haen P, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Thrombosis Risk Associated with Head and Neck Cancer: A Review. Int J Mol Sci 2019;20:E2838. [PMID: 31212608 DOI: 10.3390/ijms20112838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
8 Costa CSDO, Mafra RP, Rolim LSA, Souza LBD, Pinto LP. Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions. Braz oral res 2022;36:e071. [DOI: 10.1590/1807-3107bor-2022.vol36.0071] [Reference Citation Analysis]